Clinical overview of phototherapy for neonatal hyperbilirubinaemia.
hyperbilirubinaemia
neonates
phototherapy
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
24 Jun 2024
24 Jun 2024
Historique:
revised:
10
06
2024
received:
11
02
2024
accepted:
13
06
2024
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
26
6
2024
Statut:
aheadofprint
Résumé
The most efficient emission spectrum of light for phototherapy is blue-green light emission diode light with peak emission at 478 nm. In the irradiance interval of phototherapy, the relationship between efficacy and irradiance is almost linear, and it is negatively related to the haemoglobin. The action sites of phototherapy are the extravascular compartment and cutaneous blood. The most immature neonates treated aggressively had not only a lower frequency of neurodevelopmental impairment than conservatively treated, but also greater mortality. Intermittent and continuous phototherapy are assumed to be equally efficient. Home-based fibreoptic phototherapy is effective and safe. Important progress is still occurring in phototherapy.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Références
McDonagh AF. Controversies in bilirubin biochemistry and their clinical relevance. Semin Fetal Neonatal Med. 2010;15:141‐147.
Lamola AA, Bhutani VK, Wong RJ, Stevenson DK, McDonagh AF. The effect of hematocrit on the efficacy of phototherapy for neonatal jaundice. Pediatr Res. 2013;74:54‐60.
Ebbesen F, Madsen P, Stoevring S, Hundborg H, Agati G. Therapeutic effect of turquoise versus blue light with equal irradiance in preterm infants with jaundice. Acta Paediatr. 2007;96:837‐841.
Ebbesen F, Vandborg PK, Madsen PH, Trydal T, Jakobsen LH, Vreman HJ. Effect of phototherapy with turquoise vs. blue LED light of equal irradiance in jaundiced neonates. Pediatr Res. 2016;79:308‐312.
Ebbesen F, Rodrigo‐Domingo M, Moeller AM, Vreman HJ, Donneborg ML. Effect of blue LED phototherapy centered at 478 nm versus 459 nm in hyperbilirubinemic neonates: a randomized study. Pediatr Res. 2021;89:598‐603.
Ebbesen F, Donneborg ML, Vandborg PK, Vreman HJ. Action spectrum of phototherapy in hyperbilirubinemic neonates. Pediatr Res. 2022;92:816‐821.
American Academy of Pediatrics, Kemper AR, Newman TB, et al. Clinical practice guideline revision: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2022;150:e2022058859.
Tan KL. The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinemia. Pediatr Res. 1982;16:670‐674.
Saikia D, Kumar S, Velpandian T, Deorari AK, Biswas NR, Gupta YK. Pharmacokinetics‐based optimization of phototherapy in neonates undergoing treatment for hyperbilirubinemia. Maedica. 2021;16:603‐608.
Vandborg PK, Hansen BM, Greisen G, Ebbesen F. Dose‐response relationship of phototherapy for hyperbilirubinemia. Pediatrics. 2012;130:e353‐e357.
Morris BH, Oh W, Tyson JE, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med. 2008;359:1885‐1896.
Donneborg ML, Vandborg PK, Hansen BM, Rodrigo‐Domingo M, Ebbesen F. The impact of hemoglobin on the efficacy of phototherapy in hyperbilirubinemic infants. Pediatr Res. 2017;82:947‐951.
Mreihil K, McDonagh AF, Nakstad B, Hansen TWR. Early isomerization of bilirubin in phototherapy of neonatal jaundice. Pediatr Res. 2010;67:656‐659.
Donneborg ML, Knudsen KB, Ebbesen F. Effect of infants' position on serum bilirubin level during conventional phototherapy. Acta Paediatr. 2010;99:1131‐1134.
Guttimukkala SB, Lobo L, Gautham KS, Bolisetty S, Fiander M, Schindler T. Intermittent phototherapy versus continuous phototherapy for neonatal jaundice. Cochrane Database Syst Rev. 2023;3(3):CD008168.
Saunders NR, Liddelow SA, Dziegielewska KM. Barrier mechanisms in the developing brain. Front Pharmacol. 2012;3:1‐18.
Hansen TWR. Biology of bilirubin photoisomers. Biology of Bilirubin Photoisomers. 2016;43:277‐290.
Disapprove J, Ben MD, Vianello E, et al. The biologic effects of bilirubin photoisomers. PLoS One. 2016;11:e0148126.
Tyson JE, Pedroza C, Langer J, et al. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol. 2012;32:677‐684.
Stevenson DK, Wong RJ, Arnold CC, Pedroza C, Tyson JE. Phototherapy and the risk of photo‐oxidative injury in extremely low birth weight infants. Clin Perinatol. 2016;43:291‐295.
Itoh S, Okada H, Kuboi T, Kusaka T. Phototherapy for neonatal hyperbilirubinemia. Pediatr Int. 2017;59:959‐966.
Ebbesen F, Vreman JH, Hansen TWR. Blue‐green (≈480 nm) versus blue (≈460 nm) light for newborn phototherapy—safety considerations. Int J Mol Sci. 2023;24:461‐475.
Vogl TP. Phototherapy of neonatal bilirubinemia: Bilirubin in unexposed areas of the skin. J Pediatr. 1974;85:707‐710.
Vogl TP, Hegyi T, Hiatt IM, Polin PA, Indyk L. Intermittent phototherapy to the treatment of the premature infant. J Pediatr. 1978;92:627‐630.
Sachdeva M, Murki S, Oleti TP, Kandraju H. Intermittent versus continuous phototherapy for the treatment of non‐hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: A randomizes controlled trial. Eur J Pediatr. 2015;174:177‐181.
Chu L, Qiao J, Xu C. Home‐based phototherapy versus hospital‐based phototherapy for treatment of neonatal hyperbilirubinemia: A systematic review and meta‐analysis. Clin Pediatr. 2020;59:588‐595.
Ung B, Suils H, Cohen C, Autret F, Walter‐Nicolet E. Implementation of neonatal phototherapy with the BiliCocoon bag device in the maternity ward and the impact on mother‐infant separation. Arch Pediatr. 2023;30:283‐290.